Abstract
SUMMARY

Human bocavirus (HBoV) is a newly identified virus tentatively assigned to the family
Parvoviridae
, subfamily
Parvovirinae
, genus
Bocavirus
. HBoV was first described in 2005 and has since been detected in respiratory tract secretions worldwide. Herein we review the literature on HBoV and discuss the biology and potential clinical impact of this virus. Most studies have been PCR based and performed on patients with acute respiratory symptoms, from whom HBoV was detected in 2 to 19% of the samples. HBoV-positive samples have been derived mainly from infants and young children. HBoV DNA has also been detected in the blood of patients with respiratory tract infection and in fecal samples of patients with diarrhea with or without concomitant respiratory symptoms. A characteristic feature of HBoV studies is the high frequency of coinciding detections, or codetections, with other viruses. Available data nevertheless indicate a statistical association between HBoV and acute respiratory tract disease. We present a model incorporating these somewhat contradictory findings and suggest that primary HBoV infection causes respiratory tract symptoms which can be followed by prolonged low-level virus shedding in the respiratory tract. Detection of the virus in this phase will be facilitated by other infections, either simply via increased sample cell count or via reactivation of HBoV, leading to an increased detection frequency of HBoV during other virus infections. We conclude that the majority of available HBoV studies are limited by the sole use of PCR diagnostics on respiratory tract secretions, addressing virus prevalence but not disease association. The ability to detect primary infection through the development of improved diagnostic methods will be of great importance for future studies seeking to assign a role for HBoV in causing respiratory illnesses.
Topics

No keywords indexed for this article. Browse by subject →

References
85
[4]
Anderson, L. J. 2007. Human bocavirus: a new viral pathogen. Clin. Infect. Dis.44:911-912. 10.1086/512438
[10]
Bonvicini, F., G. Gallinella, G. A. Gentilomi, S. Ambretti, M. Musiani, and M. Zerbini. 2006. Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination. Clin. Lab.52:263-268.
[11]
Brauniger, S., J. Peters, U. Borchers, and M. Kao. 2000. Further studies on thermal resistance of bovine parvovirus against moist and dry heat. Int. J. Hyg. Environ. Health203:71-75. 10.1078/s1438-4639(04)70010-3
[17]
Dowell, S. F., T. J. Torok, J. A. Thorp, J. Hedrick, D. D. Erdman, S. R. Zaki, C. J. Hinkle, W. L. Bayer, and L. J. Anderson. 1995. Parvovirus B19 infection in hospital workers: community or hospital acquisition? J. Infect. Dis.172:1076-1079. 10.1093/infdis/172.4.1076
[18]
Durham, P. J., R. H. Johnson, H. Isles, R. J. Parker, R. G. Holroyd, and I. Goodchild. 1985. Epidemiological studies of parvovirus infections in calves on endemically infected properties. Res. Vet. Sci.38:234-240. 10.1016/s0034-5288(18)31832-0
[21]
El-Mahallawy, H. A., T. Mansour, S. E. El-Din, M. Hafez, and S. Abd-el-Latif. 2004. Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy. J. Pediatr. Hematol. Oncol.26:403-406. 10.1097/00043426-200407000-00001
[23]
Fattet, S., P. Cassinotti, and M. B. Popovic. 2004. Persistent human parvovirus B19 infection in children under maintenance chemotherapy for acute lymphocytic leukemia. J. Pediatr. Hematol. Oncol.26:497-503. 10.1097/01.mph.0000134463.09543.99
[28]
Fryer, J. F., E. Delwart, F. M. Hecht, F. Bernardin, M. S. Jones, N. Shah, and S. A. Baylis. 2007. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion47:1054-1061. 10.1111/j.1537-2995.2007.01235.x
[34]
Kaplan, N., W. Dove, A. Abu-Zeid, H. Shamoon, S. Abd-Eldayem, and C. A. Hart. 2006. Human bocavirus infection among children, Jordan. Emerg. Infect. Dis.12:1419-1420.
[41]
Lefrere, J. J., A. Servant-Delmas, D. Candotti, M. Mariotti, I. Thomas, Y. Brossard, F. Lefrere, R. Girot, J. P. Allain, and S. Laperche. 2005. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood106:2890-2895.
[42]
Lehmann, H., and S. Modrow. 2004. Parvovirus B19—ein häufig unterschätzter Infektionserreger mit vielen Krankheitsbildern. Monatsschr. Kinderheilkd.152:203-214. 10.1007/s00112-003-0880-1
[44]
Lindblom, A., A. Isa, O. Norbeck, S. Wolf, B. Johansson, K. Broliden, and T. Tolfvenstam. 2005. Slow clearance of human parvovirus B19 viremia following acute infection. Clin. Infect. Dis.41:1201-1203. 10.1086/444503
[47]
Real-time PCR in microbiology: from diagnosis to characterisation 2007

Showing 50 of 85 references

Cited By
249
Microbiological Research
Pediatrics
Metrics
249
Citations
85
References
Details
Published
Apr 01, 2008
Vol/Issue
21(2)
Pages
291-304
License
View
Authors
Cite This Article
Oliver Schildgen, Andreas Müller, Tobias Allander, et al. (2008). Human Bocavirus: Passenger or Pathogen in Acute Respiratory Tract Infections?. Clinical Microbiology Reviews, 21(2), 291-304. https://doi.org/10.1128/cmr.00030-07
Related

You May Also Like

Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms

Rodney M. Donlan, J. William Costerton · 2002

5,070 citations

Plant Products as Antimicrobial Agents

Marjorie Murphy Cowan · 1999

4,743 citations

DiarrheagenicEscherichia coli

James P. Nataro, James B. Kaper · 1998

3,781 citations

Antiseptics and Disinfectants: Activity, Action, and Resistance

Gerald McDonnell, A. Denver Russell · 1999

3,630 citations